American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hint: It's not a company usually thought of in the space.

1 Threat Teledoc and Amwell Investors Should at Least Consider

CLEVELAND & NEW YORK--(BUSINESS WIRE)--The Clinic by Cleveland Clinic™, a joint venture between Cleveland Clinic and Amwell® (NYSE: AMWL), and RubiconMD, a leader in virtual-first specialty care solutions, today announced a strategic partnership to democratize access to medical expertise and provide clinicians access to same-day specialist guidance in primary care settings. This collaboration will utilize RubiconMD's eConsult Platform to connect primary care clinicians to a panel of Cleveland C

The Clinic by Cleveland Clinic and RubiconMD Announce Partnership to Advance Access to Specialty Expertise

Teladoc

They're both breaking into high-value growth areas like behavioral health.

2 Leading Telehealth Stocks to Buy in 2021 and Beyond

BOSTON--(BUSINESS WIRE)--Amwell releases results of industry survey highlighting opportunities and obstacles for next era of digital care delivery and virtual care platforms

Amwell Industry Telehealth Survey Paints Picture of an Integrated, Streamlined Digital Care Future

Abbott Labs

CVS Health

Ginkgo Bioworks Holdings

Pfizer

Talkspace

Welltower

Thanks to the coronavirus pandemic, many people are rethinking the medical sector, boding well for healthcare stocks. The post 7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink appeared first on InvestorPlace.

7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink

BOSTON--(BUSINESS WIRE)--Amwell appoints Robert Shepardson as Chief Financial Officer and Head of Mergers & Acquisitions

Robert Shepardson of Morgan Stanley to Join Amwell's Leadership as CFO and Head of M&A

CLEVELAND--(BUSINESS WIRE)--The Clinic by Cleveland Clinic™, a joint venture between Cleveland Clinic and Amwell® (NYSE: AMWL) that aligns world-class clinical expertise with the power of innovative digital health technologies, and ReviveHealth, a company focused on bringing simple, affordable, and accessible care to all Americans, announced today a partnership to enable ReviveHealth members to obtain online expert second opinions from Cleveland Clinic's 3,500 world-renowned expert physicians v

The Clinic by Cleveland Clinic and ReviveHealth Partner to Offer Members Virtual Second Opinions On Demand

American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.

American Well (AMWL) Down 59% YTD: Should You Still Hold?

Alarm.com

ASML Hld

Boxlight

CrowdStrike

Matterport

NVIDIA

Due to the massive disruption of the novel coronavirus pandemic, these are the tech stocks to watch heading into Q4. The post The 7 Best Tech Stocks to Buy Heading Into Q4 appeared first on InvestorPlace.

The 7 Best Tech Stocks to Buy Heading Into Q4

Why It Isn't Too Late to Invest in Telehealth

Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.

Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share

Amwell cut 2022 revenue targets as telehealth visits struggle to match tough comps from 2021. The company continues to report large losses with the current 2021 EBITDA loss targeted at a massive $150 million, or nearly 60% of revenues.

Amwell: Not Doing So Well

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that Ido Schoenberg, Chairman and Co-Chief Executive Officer and Keith Anderson, Chief Financial Officer, will participate in the 19th Annual Morgan Stanley Global Healthcare Conference including a fireside chat on Monday, September 13, 2021 at 8:45 a.m. ET. A live audio webcast and replay of this presentation will be available in the investors section of Amwell's website at https://inve

Amwell to Participate in the 19th Annual Morgan Stanley Global Healthcare Conference

BOSTON--(BUSINESS WIRE)--Amwell closes its acquisitions of SilverCloud Health and Conversa Health.

Amwell Closes Acquisitions of SilverCloud Health and Conversa Health

Doximity

UpHealth

Internet healthcare companies have seen their revenue skyrocket during the pandemic. What will the future bring?

Will Telehealth Stocks Thrive After COVID?

At least one telehealth provider is here to stay, regardless of the pandemic.

Better Buy: Teladoc vs. Amwell

Every analyst's target is higher than the current price.

Wall Street Thinks You Can't Lose With This Healthcare Stock

American Well (AMWL) posts lower-than-expected loss for Q2. The spread of Delta variant compels the company to slash 2021 guidance.

American Well (AMWL) Q2 Earnings Beat, 2H21 Visit View Cut

American Well Corp (AMWL) CEO Ido Schoenberg on Q2 2021 Results - Earnings Call Transcript

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced financial results for the second quarter ended June 30, 2021. “In Q2, we were pleased to show significant progress in shifting the mix of our revenues more towards enabling technology versus visits. We expect this shift to continue in 2022 and beyond, and after our Converge roll-out to drive better margins and profitability. We are therefore confirming our Subscription, Carepoints and re

Amwell® Announces Results for Second Quarter 2021

National telehealth provider Amwell said it will acquire Portland, Ore.

Telehealth giant Amwell to acquire Portland healthtech startup Conversa

SilverCloud Health and Conversa Health both offer automation as a way to be a constant companion to patients, rather than a one-off visit.

Amwell Acquires Two Digital Health Startups For $320 Million As Telehealth M&A Frenzy Continues

BOSTON--(BUSINESS WIRE)--Amwell acquires SilverCloud Health and Conversa Health expanding its ability to improve patient care between visits

Amwell Enhances Virtual Care Platform with Two Acquisitions: SilverCloud Health and Conversa Health

BOSTON--(BUSINESS WIRE)--Healthcare Industry Veteran O'Grady to Head Growth Organization

Amwell Names Brendan O'Grady Chief Commercial & Growth Officer

BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE:AMWL) (the "Company") a national telehealth leader, today announced that it will report second quarter ended June 30, 2021 operating results on Wednesday, August 11, 2021. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update. A live audio webcast can be accessed by vi

News for American Well Corporation Stock (AMWL)